141 related articles for article (PubMed ID: 37103742)
1. Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis.
Jiao Y; Guo X; Lv Q
Breast Cancer; 2023 Jul; 30(4):647-656. PubMed ID: 37103742
[TBL] [Abstract][Full Text] [Related]
2. Surgery on Metastatic Foci is a Better Strategy for Stage IV Breast Cancer Patients with only Nonregional Lymph Node Metastasis.
Jiao Y; Guo X; Wu H; Lv Q
Adv Ther; 2023 Jul; 40(7):3247-3262. PubMed ID: 37270436
[TBL] [Abstract][Full Text] [Related]
3. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
4. Comparison of lymphangiogenesis, lymphatic invasion, and axillary lymph node metastasis in breast carcinoma.
Guleria P; Srinivas V; Basannar D; Dutta V
Indian J Pathol Microbiol; 2018; 61(2):176-180. PubMed ID: 29676352
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].
Wang WY; Meng XZ; Li N; Zeng HM; Liu JX; Feng KX; Wang PL; Wang X
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2152-2158. PubMed ID: 34275251
[No Abstract] [Full Text] [Related]
6. Impact of the obesity on lymph node status in operable breast cancer patients.
Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
[TBL] [Abstract][Full Text] [Related]
7. Tumor volume of resectable gastric adenocarcinoma on multidetector computed tomography: association with N categories.
Li H; Chen XL; Li JR; Li ZL; Chen TW; Pu H; Yin LL; Xu GH; Li ZW; Reng J; Zhou P; Cheng ZZ; Cao Y
Clinics (Sao Paulo); 2016 Apr; 71(4):199-204. PubMed ID: 27166769
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
9. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the effect of ipsilateral supraclavicular lymph node metastasis on the prognosis of N3 breast cancer].
Nilupai A; Wang JY; Li Q; Zhang P; Ma F; Yuan P; Luo Y; Cai RG; Fan Y; Li Q; Chen SS; Xu BH
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1069-1075. PubMed ID: 34695897
[No Abstract] [Full Text] [Related]
11. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
[TBL] [Abstract][Full Text] [Related]
12. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.
Sakao Y; Miyamoto H; Oh S; Takahashi N; Sakuraba M
J Thorac Oncol; 2007 Dec; 2(12):1107-11. PubMed ID: 18090583
[TBL] [Abstract][Full Text] [Related]
14. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer?
Neal CH; Daly CP; Nees AV; Helvie MA
Radiology; 2010 Nov; 257(2):335-41. PubMed ID: 20807849
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
[TBL] [Abstract][Full Text] [Related]
16. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.
Abrams MJ; Koffer PP; Wazer DE; Hepel JT
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases.
Tankéré F; Camproux A; Barry B; Guedon C; Depondt J; Gehanno P
Laryngoscope; 2000 Dec; 110(12):2061-5. PubMed ID: 11129021
[TBL] [Abstract][Full Text] [Related]
19. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Ali A; Hoyle A; Mistry H; Clarke NW
BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
[TBL] [Abstract][Full Text] [Related]
20. Tumor volume of resectable adenocarcinoma of the esophagogastric junction at multidetector CT: association with regional lymph node metastasis and N stage.
Li R; Chen TW; Hu J; Guo DD; Zhang XM; Deng D; Li H; Chen XL; Tang HJ
Radiology; 2013 Oct; 269(1):130-8. PubMed ID: 23657894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]